Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 11 04:00PM ET
36.35
Dollar change
+0.06
Percentage change
0.17
%
Index- P/E23.65 EPS (ttm)1.54 Insider Own0.01% Shs Outstand2.04B Perf Week-1.68%
Market Cap74.14B Forward P/E8.30 EPS next Y4.38 Insider Trans0.00% Shs Float2.04B Perf Month-6.39%
Income3.17B PEG4.53 EPS next Q0.55 Inst Own15.26% Short Float0.81% Perf Quarter-11.73%
Sales39.69B P/S1.87 EPS this Y2.38% Inst Trans-4.53% Short Ratio3.36 Perf Half Y-19.53%
Book/sh9.21 P/B3.95 EPS next Y8.34% ROA4.16% Short Interest16.55M Perf Year5.48%
Cash/sh2.11 P/C17.21 EPS next 5Y5.22% ROE18.18% 52W Range33.89 - 45.92 Perf YTD-1.92%
Dividend Est.1.56 (4.30%) P/FCF10.63 EPS past 5Y4.23% ROI8.66% 52W High-20.85% Beta0.66
Dividend TTM1.54 (4.23%) Quick Ratio0.53 Sales past 5Y-1.06% Gross Margin70.66% 52W Low7.26% ATR (14)0.74
Dividend Ex-DateNov 15, 2024 Current Ratio0.81 EPS Y/Y TTM-57.77% Oper. Margin18.27% RSI (14)35.48 Volatility1.34% 1.35%
Employees70212 Debt/Eq1.15 Sales Y/Y TTM9.06% Profit Margin7.97% Recom2.38 Target Price46.55
Option/ShortYes / Yes LT Debt/Eq0.95 EPS Q/Q-104.11% Payout47.48% Rel Volume1.00 Prev Close36.29
Sales Surprise-0.89% EPS Surprise12.25% Sales Q/Q1.03% EarningsOct 30 BMO Avg Volume4.93M Price36.35
SMA20-3.19% SMA50-8.68% SMA200-11.53% Trades Volume4,938,779 Change0.17%
Date Action Analyst Rating Change Price Target Change
Oct-31-24Downgrade Guggenheim Buy → Neutral
Jul-08-24Downgrade UBS Buy → Neutral
May-30-24Initiated Goldman Neutral $47
Mar-04-24Upgrade Guggenheim Neutral → Buy
Feb-13-24Upgrade Citigroup Neutral → Buy
Jan-23-24Initiated Morgan Stanley Equal-Weight $44
Jan-16-24Resumed UBS Buy
Jan-03-24Upgrade Jefferies Hold → Buy $48
Jul-14-23Initiated HSBC Securities Reduce
Mar-17-23Upgrade Deutsche Bank Hold → Buy
Nov-08-24 09:35AM
05:00AM
Nov-07-24 04:02PM
08:58AM
06:30AM
04:31AM Loading…
Nov-06-24 04:31AM
Oct-31-24 03:48PM
03:04AM
Oct-30-24 07:31PM
04:26PM
09:05AM
09:02AM
08:58AM
08:15AM
08:05AM
07:34AM Loading…
07:34AM
05:15AM
05:00AM
03:43AM
Oct-28-24 02:12AM
Oct-24-24 04:02PM
07:00AM
Oct-23-24 11:31AM
10:02AM
Oct-21-24 04:15PM
Oct-16-24 11:35AM
Oct-15-24 10:20AM
Oct-14-24 08:43AM
08:39AM
Oct-11-24 04:21PM
02:32PM Loading…
Oct-10-24 02:32PM
07:47AM
06:54AM
03:07AM
Oct-09-24 06:39PM
02:01PM
01:42PM
Oct-08-24 05:00PM
07:00AM
12:04AM
Oct-07-24 01:56PM
01:00PM
10:59AM
10:41AM
Oct-04-24 12:31PM
11:26AM
Oct-03-24 08:30AM
Sep-30-24 10:09AM
Sep-19-24 08:00AM
Sep-18-24 10:01AM
07:00AM
Sep-16-24 01:04PM
Sep-12-24 10:07AM
Sep-11-24 05:38AM
Aug-30-24 11:31AM
Aug-28-24 11:23AM
05:30AM
Aug-23-24 05:32AM
Aug-21-24 07:32AM
Aug-17-24 03:58PM
Aug-10-24 12:57PM
Aug-06-24 04:05PM
08:30AM
04:32AM
Aug-01-24 03:44PM
02:31PM
Jul-31-24 11:51AM
11:27AM
08:42AM
08:01AM
07:05AM
04:42AM
02:45AM
Jul-29-24 07:00AM
Jul-24-24 10:01AM
Jul-22-24 06:24AM
Jul-17-24 08:00AM
06:30AM
Jul-16-24 09:40AM
Jul-12-24 06:15AM
Jul-11-24 08:00AM
07:00AM
Jul-09-24 01:30PM
12:33PM
Jul-08-24 11:42PM
01:30PM
12:34PM
Jul-04-24 12:00PM
10:01AM
Jul-03-24 12:49PM
11:49AM
10:09AM
08:19AM
06:23AM
05:21AM
04:43AM
02:40AM
Jul-01-24 10:24AM
Jun-27-24 10:05PM
03:28PM
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GSK plc10% OwnerSep 27 '24Buy8.002,791,93022,335,44016,775,691Oct 01 05:54 PM
GSK plc10% OwnerDec 07 '23Buy5.003,300,00016,500,00013,983,761Jan 30 04:39 PM